S M Koenig

Summary

Affiliation: University of Virginia
Country: USA

Publications

  1. ncbi request reprint Pulmonary complications of obesity
    S M Koenig
    Department of Medicine, University of Virginia School of Medicine and the University of Virginia Health System, Charlottesville 22908 00546, USA
    Am J Med Sci 321:249-79. 2001
  2. doi request reprint Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Steven M Koenig
    Division of Pulmonary Medicine and Critical Care, University of Virginia, Hospital Drive, Private Clinics 6590, Charlottesville, VA 22908, USA
    Respir Med 102:665-73. 2008
  3. doi request reprint Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down"
    Steven M Koenig
    University of Virginia, Division of Pulmonary Medicine and Critical Care, Charlottesville, VA 22908, USA
    J Asthma 45:681-7. 2008
  4. ncbi request reprint Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice daily
    William Busse
    University of Wisconsin, Medical School, Madison 53792, USA
    J Allergy Clin Immunol 111:57-65. 2003
  5. ncbi request reprint Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol
    Nizar N Jarjour
    Pulmonary and Critical Care Medicine Section, University of Wisconsin School of Medicine, Madison, WI, USA
    J Allergy Clin Immunol 118:44-52. 2006
  6. pmc Ventilator-associated pneumonia: diagnosis, treatment, and prevention
    Steven M Koenig
    Pulmonary and Critical Care Medicine, P O Box 800546, UVa HS, Charlottesville, VA 22908, USA
    Clin Microbiol Rev 19:637-57. 2006
  7. ncbi request reprint Pulmonary disorders in the training room
    James S Pope
    Division of Pulmonary and Critical Care Medicine, University of Virginia Health System, P O Box 800546, Charlottesville, VA 22908, USA
    Clin Sports Med 24:541-64, viii. 2005

Collaborators

Detail Information

Publications7

  1. ncbi request reprint Pulmonary complications of obesity
    S M Koenig
    Department of Medicine, University of Virginia School of Medicine and the University of Virginia Health System, Charlottesville 22908 00546, USA
    Am J Med Sci 321:249-79. 2001
    ..There are numerous medical and surgical therapies for obstructive sleep apnea and obesity hypoventilation. Weight reduction in the obese is among the most effective of these measures...
  2. doi request reprint Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Steven M Koenig
    Division of Pulmonary Medicine and Critical Care, University of Virginia, Hospital Drive, Private Clinics 6590, Charlottesville, VA 22908, USA
    Respir Med 102:665-73. 2008
    ....
  3. doi request reprint Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down"
    Steven M Koenig
    University of Virginia, Division of Pulmonary Medicine and Critical Care, Charlottesville, VA 22908, USA
    J Asthma 45:681-7. 2008
    ..This study provides support that treatment of both inflammation and smooth muscle dysfunction may be necessary to achieve and maintain asthma control in patients uncontrolled on ICS...
  4. ncbi request reprint Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice daily
    William Busse
    University of Wisconsin, Medical School, Madison 53792, USA
    J Allergy Clin Immunol 111:57-65. 2003
    ..Concurrent use of an inhaled corticosteroid (ICS) and an inhaled long-acting beta2-agonist provides better overall asthma control than the use of higher doses of ICS alone...
  5. ncbi request reprint Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol
    Nizar N Jarjour
    Pulmonary and Critical Care Medicine Section, University of Wisconsin School of Medicine, Madison, WI, USA
    J Allergy Clin Immunol 118:44-52. 2006
    ..Inhaled corticosteroids (ICSs) have been shown to reverse epithelial damage and decrease lamina reticularis thickness in patients with asthma...
  6. pmc Ventilator-associated pneumonia: diagnosis, treatment, and prevention
    Steven M Koenig
    Pulmonary and Critical Care Medicine, P O Box 800546, UVa HS, Charlottesville, VA 22908, USA
    Clin Microbiol Rev 19:637-57. 2006
    ....
  7. ncbi request reprint Pulmonary disorders in the training room
    James S Pope
    Division of Pulmonary and Critical Care Medicine, University of Virginia Health System, P O Box 800546, Charlottesville, VA 22908, USA
    Clin Sports Med 24:541-64, viii. 2005
    ..This article addresses the most common pulmonary conditions athletes face and provides a framework for the diagnosis and treatment of these conditions...